Abstract
The prognosis of unresectable advanced gallbladder cancer is extremely poor. We presented a 61-year-old female with unresectable advanced gallbladder cancer who received FAP therapy, Gemcitabine + UFT therapy, and an intra-arterial FAP therapy that followed. She is still alive 18 months after the first diagnosis. It may be possible to improve the prognosis by maintaining QOL using the combination of chemotherapies such as FAP, Gemcitabine, and UFT.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cisplatin / administration & dosage
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives*
-
Doxorubicin / administration & dosage
-
Female
-
Fluorouracil / administration & dosage
-
Gallbladder Neoplasms / drug therapy*
-
Gemcitabine
-
Humans
-
Middle Aged
-
Tegafur / administration & dosage
-
Uracil / administration & dosage
Substances
-
Deoxycytidine
-
Tegafur
-
Uracil
-
Doxorubicin
-
Cisplatin
-
Fluorouracil
-
Gemcitabine